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Abstract Macrolides are a group of antibiotics structurally
characterized by a macrocyclic lactone to which one or several
deoxy-sugar moieties are attached. The sugar moieties are
transferred to the different aglycones by glycosyltransferases
(GTF). The OleI GTF of an oleandomycin producer, Strepto-
myces antibioticus, catalyzes the inactivation of this macrolide
by glycosylation. The product of this reaction was isolated and
its structure elucidated. The donor substrate of the reaction
was UDP-K-D-glucose, but the reaction product showed a
L-glycosidic linkage. The inversion of the anomeric configuration
of the transferred sugar and other data about the kinetics of the
reaction and primary structure analysis of several GTFs are
compatible with a reaction mechanism involving a single
nucleophilic substitution at the sugar anomeric carbon in the
catalytic center of the enzyme. ß 2000 Federation of European
Biochemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
Macrolides constitute a group of antibiotics mainly active
against Gram-positive bacteria. They have important clinical
applications in the treatment of bacterial infections. Their
structures are integrated by a macrocyclic lactone to which
one or several sugar moieties are attached. These carbohy-
drate ligands are, in many cases, unusual, and they serve as
molecular recognition elements critical for biological activity.
The suppression of these ligands produces abolition or a dra-
matic decrease in activity. In the same way, variations in the
sugar composition of these molecules, as changes or additions,
can also produce important e¡ects, varying from increase of
activity to its total suppression. Because of these considera-
tions, many studies have been performed about the biosynthe-
sis of these molecules in order to apply the acquired knowl-
edge in the emerging ¢eld of combinatorial biosynthesis, using
them as source to obtain new unnatural compounds suscep-
tible to possess interesting applications. The sugar moieties
are transferred to the di¡erent aglycones as late steps during
the biosynthesis by means of glycosyltransferases (GTF). Im-
portant e¡orts have been carried out on the study of these
enzymes in order to apply them for combinatorial biosynthe-
sis. During the last years, several genes encoding GTFs in-
volved in the transfer of sugars to various aglycones have
been cloned and sequenced, and their genetic relations ana-
lyzed [1^11]. However, because of the unavailability of sub-
strates for these reactions, biochemical information about
these enzymes is scarce.
Most macrolides are produced by streptomycetes. The bio-
synthesis of a potential lethal antibiotic by these microorgan-
isms requires the existence of a self-resistance mechanism in
the producing microorganism to avoid cell suicide. One of the
resistance mechanisms described in macrolide producing or-
ganisms is the existence of intracellular GTF [1,2,9]. These
enzymes inactivate macrolides by glycosylation of a hydroxyl
group present in one of the 6-deoxy-hexoses attached to the
macro-lactone ring [12,13]. This enzymatic activity was ini-
tially found in the non-macrolide producer strain Streptomy-
ces lividans [1] and in the oleandomycin (OM) producer Strep-
tomyces antibioticus [12]. Afterwards, it has been found that
such enzyme activity is also present in 15 out of 32 strepto-
mycetes producers of di¡erent polyketide antibiotics [14]. The
OM producer contains a second enzyme activity that converts
the inactive glycosylated OM (Glc-OM) into active antibiotic
by removing the glucose moiety from the inactive compound
[12]. This glycosidase has been puri¢ed from the culture super-
natant of this microorganism [15]. Consequently, S. antibioti-
cus, which possesses ribosomes that are sensitive to OM all
along the cell cycle and even during the production phase of
the antibiotic [16], might use this inactivation/reactivation sys-
tem as a self-resistance mechanism to survive during the bio-
synthesis of the drug. In the OM biosynthetic gene cluster of
S. antibioticus the gene (oleI) that encodes the OM GTF
(OGT) has been identi¢ed [9].
Analysis of di¡erent GTFs and multiple sequence align-
ments have shown a great similarity between all known
GTFs, including OGT. The di¡erences observed in the pri-
mary structure of these enzymes become even diminished
when predictive protein structure analysis as multiple pre-
dicted secondary structure alignments or hydrophobic cluster
analysis are performed (L.M. Quiro¤s, unpublished). This is a
good support for a common evolutionary origin of all these
proteins, and suggests that all of them could share analogous
three-dimensional fold and chemical and kinetic mechanisms.
OGT is an enzyme that catalyzes the transfer of a glucose
moiety from UDP-glucose (UDP-Glc) to OM. Both substrates
of the reaction are available, what makes this enzyme a good
candidate to get further into the biochemical knowledge of
this group of enzymes. OGT has been puri¢ed and the kinetics
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of the reaction analyzed [17]. Interestingly, in the OM pro-
ducer organism, another GTF gene (oleD) encoding a GTF
able to transfer a glucose moiety from UDP-Glc to many
macrolides and located outside the OM gene cluster has
been cloned [2]. This enzyme has been recently puri¢ed and
the kinetics of the reaction shown to be analogous to that of
OGT [18], what agrees with the hypothesis mentioned above.
In this paper we report the structure determination of the
product of the reaction catalyzed by OGT, showing an inver-
sion of the anomeric con¢guration of the transferred glucose,
and correlating this observation with a probable reaction
mechanism for this group of enzymes.
2. Materials and methods
2.1. Materials
OM and UDP-Glc were purchased from Sigma. UDP-[6-3H]glucose
(speci¢c activity 17.5 Ci mmol31) was from Amersham. Acetonitrile
(HPLC grade) was from Merck. All other chemicals were obtained
from commercial sources and were of analytical grade.
2.2. Puri¢cation of the OGT
The puri¢cation of the OGT encoded by the oleI gene was per-
formed as previously described [17].
2.3. Puri¢cation of the product of the reaction
OM glycosylation was performed during 12 h at 30‡C in a reaction
mixture containing 6 mM OM, 9 mM UDP-Glc and 25 Wg of pure
OGT in Tris^HCl bu¡er 25 mM pH 8.0. The total volume of the
reaction was 5 ml. The reaction was monitorized adding to the mix-
ture a small amount of UDP-[3H]Glc (5 WCi), extracting small ali-
quots (25 Wl) at di¡erent times and determining the incorporation of
radioactivity into OM as previously described [17]. The OM-Glc was
extracted and puri¢ed as previously described [18].
2.4. NMR spectroscopy
NMR spectra were recorded at 298 K on a Bruker AMX 400
spectrometer operating at 400.13 MHz and 100.61 MHz for 1H and
13C, respectively, using a 5 mm OXI 1H/13C/15N/31P reverse probe
including a z-gradient coil. CD3OD was used as solvent and chemical
shifts were referenced internally to tetramethylsilane (TMS). Sample
concentration was 0.1 mM. Pulse widths were 8.5 Ws/13.7 Ws for
1H/13C at an attenuation level of 3 dB on both channels. A 5% sinus
truncated shaped pulse gradient of 1 ms was used with values 5:3:4
for both gs-HMQC and gs-HMBC. Standard Bruker software has
been used to acquire and process the 13C DEPT, gs-HMQC, and
gs-HMBC spectra. Selected parameters for 1H, 13C 2D correlations:
sweep width 2400 Hz for 1H and 19 000 Hz for 13C; 2048U512 data
set; pre-acquisition delay 2 s; number of scans 16^32; magnitude
mode; data processing using zero ¢lling in the F1 domain and shifted
sinus-bell apodization of factor 0 in both dimensions. For HMQC
GARP decoupling of 13C was used during acquisition.
3. Results and discussion
The structure of the product of the reaction catalyzed by
OGT is unknown, although some indirect approaches have
been described [12]. To elucidate the structure of this com-
pound, we puri¢ed the enzyme, performed glycosylation reac-
tions and puri¢ed several miligrams of the product of the
reaction as described in Section 2. The ¢rst evidence for the
glycosylation in the NMR spectra was the appearance of six
additional 13C NMR signals respective to the initial OM sub-
strate. The rest of the signals presented no signi¢cant changes
with respect to OM, which suggests the same macrocyclic
structure plus a new sugar ring. The structural characteriza-
tion of the compound was performed by the complete assign-
ment of all the 1H and 13C NMR spectral signals. For this
purpose, apart from the 1H and 13C NMR spectra, other
experiments as DEPT, 1H, 13C HMQC and HMBC were nec-
essary. The strategy of the work was to establish in the
HMBC spectrum the connectivity of a known carbon with
protons separated by two or three bonds and then to ¢nd
out in the HMQC spectrum the direct response via 1JCH
of these protons with their corresponding carbon nuclei.
The most evident starting point for the characterization
are the 13C carbonyl signals from the C1 (N 178.82) and C9
(N 210.56) (Table 1) macrocyclic ring carbons, as they showed
the highest unshielding in the 13C NMR spectra. The HMBC
spectrum showed correlation peaks through 2 or 3 bonds
between C1 and the proton signals H2, H3, H13 and H315,
while C9 correlates with H7, H10, H11, H18 and H319. The
rest of the macrocyclic 1H and 13C signals could be sequen-
tially assigned using the information contained in the HMBC
spectrum. The identi¢cation of the sugar moieties came from
the correlation peaks seen in the same HMBC experiment
between protons H5 and H3 with the anomeric carbons C1P
and C1Q, respectively. From these starting points the rest of
the sugar rings could be easily assigned using the same process
discussed above. The direct evidence for the glycosylation
position came from the cross peak found between H2P and
C1R, and between H1R and C2P. The conformation of the
sugar rings has been deduced from the scalar coupling con-
stants of the protons, as is shown in Fig. 1. According to the
fact that changes in the sugar composition of these molecules
can produce important changes in biological activity, this Glc-
OM molecule is unable to act on the ribosomes, and therefore
it can not inhibit protein biosynthesis [9].
Fig. 1. Chemical structure of Glc-OM.
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Interestingly, the coupling constant between H1R and H2R
is 7.7 Hz, only compatible with an axial position of both
protons on the sugar ring. This result implies that the glyco-
sidic linkage of the glucose is L. Considering that the substrate
of the reaction was UDP-K-D-glucose, an inversion of the
anomeric con¢guration occurred during the reaction. It has
been pointed out that the occurrence or non-occurrence of an
inversion in an enzyme reaction may a¡ord evidence of the
mechanism of the reaction [19]. If the reaction involves only
one transfer of the group, the result will be an inversion; if it
involves two successive transfers, the e¡ects will cancel and no
inversion will be observed. This inversion can only a¡ect the
particular atom at which the transfer occurs. The two possi-
bilities have been described for other types of GTFs not in-
volved in macrolide biosynthesis [20^22]. Both mechanisms
are summarized in Fig. 2. In the inverting mechanism, a single
nucleophilic substitution at the sugar anomeric carbon leads
to the formation of a L-linkage from an K-linked donor. The
retaining mechanism involves the transient formation of a
glycosyl enzyme and its subsequent addition to the acceptor,
resulting in the formation of an K-linkage from an K-linked
donor. The retaining mechanism can proceed through oxocar-
benium ion-like transition states [22], or may follow a con-
certed reaction mechanism, through a transition state which
avoids formation of the oxocarbenium ion reaction intermedi-
ate [23]. Additional considerations can be made using the
kinetic information previously reported for OGT [17]. The
retaining mechanism is more compatible with a reaction in
which the enzyme reacts with one substrate to give a cova-
lently modi¢ed enzyme and releases one product, reacting
then with the second substrate. The reaction would proceed
in a compulsory order through a series of binary complexes,
and no ternary complex would be formed. Nevertheless, the
kinetic mechanism described for OGT implies the binding of
the substrates to the enzyme in a compulsory order, ¢rst OM
and then the UDP-Glc to form a ternary complex in which
the exchange reaction takes place; then, the release of the
products also occurs in a compulsory order, UDP ¢rst fol-
Table 1
1H and 13C NMR data of Glc-OM in CD3OD at 25‡C
Site N 13C
(ppm)
N 1H
(ppm)
Multiplicity J(H, H)
(Hz)
1 178.82 ^
2 46.20 2.73 m
3 80.39 3.81 dd 1.5, 4.6
4 46.47 1.83 m
5 83.59 3.49 d 9.8
6 34.91 1.89 m
7 33.59 1.58 dd 10.8, 15.3
2.50 dd 4.2, 15.3
8 65.32 ^
9 210.56 ^
10 46.50 3.17 dc 1.7, 6.8
11 71.29 3.76 dd 1.7, 9.4
12 43.27 1.66 ddc 1.8, 6.9, 9.4
13 72.21 5.32 dc 1.8, 6.6
14 18.59 1.28 d 6.6
15 13.89 1.16 d 7.2
16 10.46 1.18 d 7.1
17 20.00 1.13 d 6.7
18 50.90 2.71 d 5.0
2.76 d 5.0
19 8.75 0.98 d 6.8
20 10.11 0.98 d 6.9
1P 104.00 4.34 d 7.3
2P 82.61 3.35 dd 7.3, 10.4
3P 66.91 2.78 m
4P 30.57 1.27 m
1.78 m
5P 70.10 3.55 m
6P 21.82 1.21 d 6.1
7P, 8P 41.06 2.27 s
1Q 100.05 4.95 dd 1.2, 3.7
2Q 35.84 1.44 ddd 3.7, 11.7, 12.7
2.37 ddd 1.2, 4.6, 12.7
3Q 79.39 3.41 ddd 4.6, 8.9, 11.7
4Q 77.68 3.02 dd 8.9, 9.0
5Q 70.89 3.69 m
6Q 18.99 1.24 d 6.2
7Q 57.66 3.42 s
1R 107.77 4.40 d 7.7
2R 76.81 3.22 dd 7.7, 9.0
3R 78.61 3.35 m
4R 72.10 3.28 m
5R 78.43 3.29 m
6R 63.66 3.67 dd 5.5, 11.7
3.84 dd 2.3, 11.7
Fig. 2. Proposed mechanisms for retaining and inverting GTF.
Fig. 3. Kinetic mechanism of OGT.
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lowed subsequently by Glc-OM (Fig. 3). The same mechanism
has been described for the other GTF isolated from S. anti-
bioticus using the macrolide lankamycin as substrate [18].
These results are more in agreement with a mechanism that
would involve the inverting reaction, implying a single nucle-
ophilic substitution in a ternary complex at the catalytic cen-
ter of the enzyme.
Another interesting aspect of the mechanism is that it im-
plies the presence of a nucleophile at the catalytic center.
Recently, kinetic studies at di¡erent pHs for the GTF encoded
by oleD from S. antibioticus have determined molecular pK
values for V and V/Km placed between 6.6 and 6.8 [18], values
within the pK range described for histidine when present at
the active site [24], and suggesting that this amino acid could
be involved in the catalytic process. Mechanisms for GTFs
using oligosaccharides as donor have been determined by la-
beling, crystallography and kinetic analysis of several en-
zymes, showing their active sites a pair of carboxylic acids
that play key roles in the mechanisms [22]. Nevertheless,
much less information is available on nucleotide phospho-sug-
ar dependent GTFs, as those implied in the biosynthesis of
macrolides and other polyketide molecules. The imidazole side
chain of histidine is a ternary amine in which the atoms bound
to the nitrogen are held back in the ¢ve-membered ring, thus
avoiding steric hindrance. This amine has a pKa value near 7,
what makes it extremely e¡ective as a nucleophilic catalyst
[25]. In addition, analysis of the amino acid sequences of
several GTFs involved in the biosynthesis of polyketides
showed a very well conserved region including one or two
histidine residues depending on the GTF (Fig. 4). These con-
siderations again correlate very well with the proposed mech-
anism, and suggest that the amino acid histidine present at
this conserved region could play an important role in the
catalytic activity of the enzyme. However, not so well con-
served regions including carboxylic acids can be detected in
the alignments for the di¡erent macrolide GTFs, although
histidine residues have also been shown to be important in
terms of substrate binding and transition state stabilization in
some oligosaccharide-dependent GTFs.
In conclusion, all the results and considerations given above
support a chemical mechanism for the OGT in which an in-
version at the glucose anomeric carbon takes place, leading to
the formation of a L-linkage from an K-linked donor. This
mechanism is supported by the elucidated structure of the
reaction product, but it is also consistent with the kinetic
mechanism described for the macrolide GTFs codi¢ed by
the oleI and oleD genes from S. antibioticus. Furthermore, it
could also be supported by the kinetic studies at di¡erent pHs
performed for the GTF encoded by oleD, and with the exis-
tence of a well-conserved region including one or two histi-
dines in all GTFs so far described involved in the biosynthesis
of polyketides. The similarities in the sequences and predicted
structures from these enzymes makes agreeable to extend this
mechanism to this family of enzymes.
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